Related Experiment Video
Updated: Jul 27, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Thrombolytic therapy for acute myocardial infarction: the elderly population
Insights
Elderly patients with acute myocardial infarction (AMI) can benefit from early thrombolytic therapy, despite concerns about bleeding risks. This review examines AMI treatment in older adults, offering guidelines for protocol development.
Area of Science:
- Cardiology
- Geriatric Medicine
Background:
- Coronary artery disease is a leading cause of death in individuals over 65.
- Over half of acute myocardial infarction (AMI) hospitalizations are now in patients older than 65, a trend expected to rise.
Purpose of the Study:
- To review the current literature on thrombolytic therapy for AMI in the elderly population.
- To provide guidelines for developing treatment protocols for AMI in older adults.
Main Methods:
- Review of existing scientific literature on thrombolytic therapy for AMI.
- Analysis of data concerning the benefits and risks of thrombolytic therapy in elderly patients.
Main Results:
- Early thrombolytic therapy for AMI can limit myocardial damage, preserve heart function, reduce heart failure, and decrease mortality.
- Exclusion of elderly patients from studies is often based on assumed higher risks of hemorrhagic complications, potentially outweighing reperfusion benefits.
Conclusions:
- Evidence suggests that the benefits of early reperfusion therapy for AMI in the elderly may outweigh the risks.
- Further research and specific guidelines are needed for effective thrombolytic treatment protocols in older AMI patients.
Abstract:
Coronary artery disease is the most common cause of death in persons older than 65 years. More than half of all patients hospitalized for acute myocardial infarction (AMI) are now older than 65, with this percentage expected to increase significantly in subsequent years. The current evidence regarding the treatment of AMI indicates that early thrombolytic therapy can limit the extent of myocardial necrosis, preserve left ventricular function, decrease the incidence of congestive heart failure, and reduce mortality in patients with AMI. Most studies have adhered to empiric recommendations to exclude elderly patients, based on the assumption that in the elderly the risks of serious hemorrhagic complications after thrombolytic therapy outweigh the potential benefits of early reperfusion. This article reviews the current literature regarding use of thrombolytic agents in treating AMI in the elderly population with some guidelines for protocol formation.
More Related Videos
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

